The SHPA Residency Program, launched on 5 September, has hit a major milestone – site applications are now open.
SHPA CEO Kristin Michaels says support for the Residency Program has been overwhelming, and the groundwork has now been laid for the program’s inaugural year of operation.
“The application process for sites to be part of the inaugural SHPA Residency Program has opened,” Michaels says.
“This demonstrates robust progress with the establishment of a national two-year formal development program for pharmacists in their ‘foundation’ years.”
“The SHPA Residency Program will have a positive effect on the future of the profession and will provide a foundation for a variety of exciting career pathways for pharmacists.”
Michaels says the SHPA Residency Program offers meaningful value propositions for Australia’s hospitals and hospital pharmacists.
“The flexibility built into the program will ensure it can operate effectively within different hospital settings, meeting local needs,” she says.
“It will also facilitate transfer of skills across practice sites, utilise consistent resources and promote reliable, quality evaluation across a range of training situations,” she says.
“The Residency Program is one of a number of SHPA priority initiatives that ensure we are offering real value to our members and building robust foundations for the growth and evolution of hospital pharmacy.”
To find out more about the SHPA Residency Program or to make an accreditation application, click here.